Acarix AB (publ) (ACARIX.ST)

Compare

0.2280

+0.0030

+(1.33%)

At close: April 4 at 5:29:41 PM GMT+2

Acarix Named 2025 Digital Innovation Winner by Global Cardiovascular Awards

Acarix, a global leader in AI and acoustics-based cardiac diagnostics, has been awarded the 2025 Digital Innovation Award with an honorable mention for Innovation in Cardiac Imaging at the Global Cardiovascular Awards in London for its breakthrough CADScor® System.

PR Newswire 22 days ago

ACIXF
Acarix Publishes Year-End Report 2024

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial results. "The company continues to demonstrate exceptional progress in its pursuit of operational excellence and sustainable growth, fueled by U.S. market expansion in sales and strategic partnerships, continued positive progress with CMS reimbursement, and strong Q4 and 2024 overall financial performance," said Acarix's leadership team in a joint statement. This advancement underscor

PR Newswire last month

ACIXF
Acarix Partners with Geo-Med to Extend the Availability of the CADScor System for Veterans

Acarix, a pioneer in the development of groundbreaking acoustic-based cardiac diagnostic solutions, is proud to announce a new strategic partnership with Geo-Med, LLC, a renowned Service-Disabled Veteran-Owned Small Business that specializes in medical and surgical products for the Department of Veterans Affairs and Department of Defense.

PR Newswire last month

ACIXF
Acarix Expands U.S. Reimbursement Coverage for CADScor System for use in Emergency and Outpatient Settings

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has decided that the CPT code 0716T - the CADScor® System - shall be assigned to APC 5733 including status indicator assignment to "S" (separately payable) for calendar year 2025. The CMS ruling means standalone fixed reimbursement is now possible for the CADScor System in outpatient settings.

PR Newswire 4 months ago

ACIXF
Acarix AB (publ) publishes Interim Report, April - June 2024

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 2024. The company achieved record-breaking patch sales and record-breaking gross profit, driven by the success of its new sales model coupled with key strategic initiatives involving commercial expansion and clinical activities. These results highlight the company's growing market presence and commitment to innovation in the cardiac diagnostics space.

PR Newswire 7 months ago

ACIXF
Acarix expands within US wellness exam market

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces expanded use of the CADScor System within wellness exams as part of self-insured companies' health plans. As healthcare costs continue to rise, the CADScor System has now been proven to be an easy and quick strategy to risk stratify patients for significant coronary artery disease.

PR Newswire 7 months ago

ACIXF
Acarix Announces Shares Are Now Being Traded on the OTCQB Under the Ticker ACIXF

VANCOUVER, BC / ACCESSWIRE / July 30, 2024 / Acarix CEO Aamir Mahmood joined Steve Darling from Proactive to share news the company has begun trading on the OTCQB Market in the United States, under the ticker symbol ACIXF. This listing complements ...

ACCESS Newswire 8 months ago

ACIXF
Acarix Shares Begin Trading on the US-based OTCQB Market

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce that the Acarix shares (OTCQB: ACIXF) begin trading today on the OTCQB Market in the US. Acarix´s shares will in parallel to its current Nasdaq First North Growth market listing in Stockholm, be traded with a US ticker symbol and a share price in USD.

PR Newswire 8 months ago

ACIXF
Acarix announces the initiation of the first US-based clinical workflow evaluation study

Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the initiation of the first US-based clinical study to collect real-world data to compare workflows between traditional stress tests and the CADScor System. The focus is on identifying non-obstructive Coronary Artery Disease (CAD) in chest pain patients, with the ultimate goal of improving discharge from Emergency Departments and Clinics in the United States.

PR Newswire 11 months ago

ACIXF
New Health Economic Analysis Presented at ACC Highlights the Acarix CADScor System's Cost-Effectiveness

Acarix, a leader in acoustic-based Cardiac Diagnostics, is pleased to announce the results from a 2024 American College of Cardiology (ACC) poster presentation by Suzanne Baron, MD, MSc, Director of Interventional Cardiology Research, Massachusetts General Hospital and Faculty at The Baim Institute for Clinical Research, to assess the cost-utility of the CADScor System for the evaluation of coronary artery disease (CAD) in a low-risk patient population presenting to the Emergency Department (ED)

PR Newswire 11 months ago

ACIXF

Performance Overview

Return	ACARIX.ST	OMX Stockholm 30 Index (^OMX)
YTD	-9.16%	-7.89%
1-Year	-2.15%	-9.30%
3-Year	-58.24%	+7.06%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Acarix AB (publ) (ACARIX.ST)

Acarix Named 2025 Digital Innovation Winner by Global Cardiovascular Awards

Acarix Publishes Year-End Report 2024

Acarix Partners with Geo-Med to Extend the Availability of the CADScor System for Veterans

Acarix Expands U.S. Reimbursement Coverage for CADScor System for use in Emergency and Outpatient Settings

Acarix AB (publ) publishes Interim Report, April - June 2024

Acarix expands within US wellness exam market

Acarix Announces Shares Are Now Being Traded on the OTCQB Under the Ticker ACIXF

Acarix Shares Begin Trading on the US-based OTCQB Market

Acarix announces the initiation of the first US-based clinical workflow evaluation study

New Health Economic Analysis Presented at ACC Highlights the Acarix CADScor System's Cost-Effectiveness

Performance Overview